BA
GILD icon

Bridgewater Advisors’s Gilead Sciences GILD Stock Holding History

Bridgewater Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$798K Sell
5,999
-159
-3% -$22.3K 0.05% 171
2025
Q4 		$795K Buy
6,158
+64
+1% +$7.78K 0.05% 176
2025
Q3 		$752K Sell
6,094
-54
-0.9% -$6.14K 0.05% 176
2025
Q2 		$702K Buy
6,148
+510
+9% +$54.3K 0.05% 180
2025
Q1 		$588K Buy
+5,638
New +$582K 0.05% 197

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bridgewater Advisors's GILD Position: Q1 2026 in Review

Bridgewater Advisors reduced its Gilead Sciences (GILD) stake by 2.6% in Q1 2026, selling an estimated $22.3K and leaving 5,999 shares worth $798K. The position accounts for 0.05% of the portfolio, ranked #171.

Bridgewater Advisors first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bridgewater Advisors held 5,999 shares of Gilead Sciences worth $798K as of Q1 2026.
  • Bridgewater Advisors sold 159 Gilead Sciences shares in Q1 2026, an estimated $22.3K.
  • Gilead Sciences made up 0.05% of Bridgewater Advisors's portfolio in Q1 2026, its #171 holding.
  • Bridgewater Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.